https://www.prnewswire.com/news-releases/oncopeptides-pepaxti-has-been-granted-marketing-authorization-in-the-uk-301675786.html
Oncopeptides' Pepaxti has been granted marketing authorization in the UK
/PRNewswire/ -- Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat...
has beenmarketing authorizationpepaxtigranteduk
https://www.prnewswire.com/news-releases/oncopeptides-announces-the-market-potential-for-pepaxti-in-europe-301672591.html
Oncopeptides announces the market potential for Pepaxti in Europe
/PRNewswire/ -- Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat...
the marketannouncespotentialpepaxtieurope
https://www.prnewswire.com/news-releases/oncopeptides-announces-the-market-potential-for-pepaxti-in-europe-301672626.html
Oncopeptides announces the market potential for Pepaxti in Europe
/PRNewswire/ -- Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on research and development of therapies for difficult-to-treat...
the marketannouncespotentialpepaxtieurope